Advanced search
Publication Cover
Clinical Toxicology Volume 55, 2017 - Issue 5
Submit an article Journal homepage
865
Views
15
CrossRef citations to date
0
Altmetric
Clinical Research

Accuracy of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity in modified-release paracetamol overdose

Anselm WongVictorian Poisons Information Centre and Austin Toxicology Service, Heidelberg, Australia; ;School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia; Correspondence[email protected]
View further author information
,
Marco L. A. SivilottiDepartments of Emergency Medicine and of Biomedical & Molecular Sciences, Queen’s University, Kingston, Canada; View further author information
&
Andis GraudinsSchool of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia; ;Emergency Medicine and Toxicology Research, Monash Health, Victoria, AustraliaView further author information
Pages 346-351 | Received 08 Dec 2016, Accepted 29 Jan 2017, Published online: 15 Feb 2017

References

  • Mowry JB, Spyker DA, Brooks DE, et al. 2014 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 32nd annual report. Clin Toxicol. 2015;53:962–1147.
  • Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–954.
  • Graudins A, Pham HN, Salonikas C, et al. Early presentation following overdose of modified-release paracetamol (Panadol Osteo) with biphasic and prolonged paracetamol absorption. N Z Med J. 2009;122:64–71.
  • Wong A, Sivilotti ML, Dargan PI, et al. External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol. 2015;53:807–814.
  • Sivilotti MLA, Green TJ, Langmann C, et al. Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose. Clin Toxicol. 2010;48:793–799.
  • Chomchai S, Chomchai C. Predicting acute acetaminophen hepatotoxicity with acetaminophen-aminotransferase multiplication product and the Psi parameter. Clin Toxicol. 2014;52:506–511.
  • MonashHealth [Internet]. Welcome to Monash Health webpage. 2016 [cited 2016 Nov 24]. Available from: http://www.monashhealth.org/page/About_Us
  • Daly FF, Fountain JS, Murray L, et al. Guidelines for the management of paracetamol poisoning in Australia and New Zealand–explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust. 2008;188:296–301.
  • Graudins A. Overdose with modified-release paracetamol (Panadol Osteo) presenting to a metropolitan emergency medicine network: A case series. Emerg Med Australas. 2014;26:398–402.
  • Wong A, Graudins A. Simplification of the standard three-bag intravenous acetylcysteine regimen for paracetamol poisoning results in a lower incidence of adverse drug reactions. Clin Toxicol. 2016;54:115–119.
  • Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics. 1975;55:871–876.
  • Offerman S, Young M. Use of the initial acetaminophen concentration times serum aminotransferase product to predict significant liver enzyme elevations after acetaminophen overdose. Clin Toxicol. 2011;49:591.
  • Laskey D, Neavyn M. APAP × AT as a hepatotoxicity predictor in patients with acetaminophen ingestions of chronic, subacute, or unknown time. Clin Toxicol. 2015;53:677–678. Abstracts NACCT, San Francisco, CA, United States.
  • Nacca NE, Hodgman M. APAP × AT in staggered, chronic and time unknown acetaminophen overdoses. Clin Toxicol. 2015;53:391. EAPCCT Abstracts, St Julian’s, Malta.
  • MHRA [Internet]. Benefit risk profile of acetylcysteine in the management of paracetamol overdose. 2012 [cited 2016 Dec]. Available from: https://www.gov.uk/drug-safety-update/treating-paracetamol-overdose-with-intravenous-acetylcysteine-new-guidance

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.